TL-895, TL-895
MS200662_0001
Phase 2 small_molecule active
Quick answer
TL-895, TL-895 for B Cell Malignancies and Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- B Cell Malignancies and Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active